×

Targeting EBV-infected B-cells may help prevent or treat MS: Study

When immune B-cells mistakenly recognize the body’s own nerve tissue, they can shut themselves down to prevent damage, but infection with the Epstein-Barr virus (EBV) can trick B-cells into surviving and becoming activated in the brain instead of being eliminated by normal immune safety mechanisms,…

Portable MRI shows strong match with standard scans in neurology clinics

Hyperfine’s Swoop system, the first U.S. Food and Drug Administration (FDA)-cleared AI-powered portable MRI system for the brain, showed strong diagnostic agreement with conventional MRI scans and was preferred by patients, according to new study results. Because Swoop can be used in neurology clinics, it…

Are we thinking of EBV the wrong way?

Tweet There are many people who view that EBV is the cause of MS….but I put forward an idea that EBV is at the centre of alot more problems than MS. Remember about 10% of the population develop autoimmunities compared to the 0.1% who develop…

Dan’s healing: The night before

The night before surgery has a very particular weight to it. It is not quite fear, not quite calm, but a tender in-between space where love and worry sit side by side. I find myself suspended in that space tonight as my husband, Dan, prepares…

Brenig launches Phase 1 trial of small molecule therapy for MS

Brenig Therapeutics has launched an early Phase 1 clinical trial to evaluate its experimental small molecule BT-409 in healthy volunteers. The therapy is being developed for people with multiple sclerosis (MS) and other chronic neurologic conditions. It is aimed at blocking inflammatory responses by targeting the…

Jumpstarting 2026

The wheels have turned again, bringing us to the beginning of a brand-new year. This is the perfect time to reflect on the past year and identify the changes one would like to make this year to bring more growth … Continue reading → Source:…